See All Slides - tctmd.com

Slides

Presentation TCT 2013

Treatment of Cardiogenic Shock: Less Clear than Ever?

Presenter: Holger Thiele

October 30, 2013

Presentation TCT 2013

Case Presentation 1: My Most Difficult Retrograde Approach Case in 2013

Presenter: R. Michael Wyman

October 30, 2013

Presentation TCT 2013

Lessons Learned from PARTNER 2A and SURTAVI: Device Specificity, Trial Design, Endpoints, and Future Low-risk Studies

Presenter: Jodi Akin

October 30, 2013

Presentation TCT 2013

Role of EVAR in the Treatment of Ruptured AAA

Presenter: Christopher Zarins

October 30, 2013

Presentation TCT 2013

Keynote Address: FDA-CDRH in the Next Decade – A Vision for Change

Presenter: Christy Foreman

October 30, 2013

Presentation TCT 2013

For Mitral Valvuloplasty in Patients with Very Large Left Atrium

Presenter: Ted Feldman

October 30, 2013

Presentation TCT 2013

Practical and Meaningful Clinical Trial Pathways for New Mitral Valve Therapies

Presenter: Paul Grayburn

October 30, 2013

Presentation TCT 2013

Motion: PFO Occlusion in a Patient Presenting with Stroke Reduces Recurrence - For: The Evidence Base is Clear Enough – All PFOs Should be Closed!

Presenter: Stephan Windecker

October 30, 2013

Presentation TCT 2013

Navigating the Stent Era (from Bare Metal to Drug-Eluting): The Transformation of PCI

Presenter: Patrick Serruys

October 30, 2013

Presentation TCT 2013

Emerging Paradigms: Multidisciplinary Heart Teams and Society-Based Registries

Presenter: E. Murat Tuzcu

October 30, 2013

Advertisement

Slides

Treatment of Cardiogenic Shock: Less Clear than Ever?

Case Presentation 1: My Most Difficult Retrograde Approach Case in 2013

Lessons Learned from PARTNER 2A and SURTAVI: Device Specificity, Trial Design, Endpoints, and Future Low-risk Studies

Role of EVAR in the Treatment of Ruptured AAA

Keynote Address: FDA-CDRH in the Next Decade – A Vision for Change

For Mitral Valvuloplasty in Patients with Very Large Left Atrium

Practical and Meaningful Clinical Trial Pathways for New Mitral Valve Therapies

Motion: PFO Occlusion in a Patient Presenting with Stroke Reduces Recurrence - For: The Evidence Base is Clear Enough – All PFOs Should be Closed!

Navigating the Stent Era (from Bare Metal to Drug-Eluting): The Transformation of PCI

Emerging Paradigms: Multidisciplinary Heart Teams and Society-Based Registries

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content